By: 7 January 2013

gekoTM from Firstkind helps prevent DVT

The gekoTM from Firstkind is an innovative device for the prevention of Deep Vein Thrombosis. The device, which is attached to the back of the knee is designed to increase blood circulation to a rate of up to 70 percent to that achieved by walking, through electro-stimulation.

A recent clinical assessment, conducted by John Fletcher, Professor of Surgery, University of Sydney and Westmead Hospital, Australia has endorsed the gekoTM device as ideal for post-surgical applications. “There is a definite need to have a better way of dealing with patients that are contraindicated to current standard prophylactic modalities and are at high risk of DVT,” Fletcher said. “And this device certainly has the potential to fulfill this need.”

The gekoTM device was developed in the UK following research at St Bartholomew’s Hospital and William Harvey Research Institute, Queen Mary, University of London, led by Arthur Tucker and Duncan Bain. 

The gekoTM device is CE marked, but is not cleared by the FDA and is unavailable for sale in the USA.